OakChart

SIGA Technologies Inc

SIGAHealthcare·Drug Manufacturers - Specialty & Generic·USA·Micro·NASD·Nov 11 • 3:59 PM ET

3.14+0.01 (0.32%)
2026-11-12 03:55 CET
Market cap
225.61 USD m
Revenue, TTM
52.36 USD m
Net income, TTM
0.69 USD m
Free cash flow, TTM
-11.57 USD m
EPS diluted, TTM
0.01
P/E
345.05
Compare

Price

SIGA against its 20, 50 and 200-day averages
2050200earnings
3.004.005.006.002.0M4.0MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26SIGAclose 3.1420-day 3.1450-day 3.19200-day 4.083.1452w high52w low

50.0% under the 52-week high of 6.29 on 3 Feb 2026. 52-week low 2.83 on 12 Aug 2026. Last 15 sessions, 22.2% high to low

Volume 0.83× normal · the line is the 50-bar volume average

Profile

SIGA
52-week range, 9% of the way up
2.836.29

SIGA Technologies, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for medical needs and biothreats. The firm develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other viruses. It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. The company was founded by Steven Oliveira on December 28, 1995 and is headquartered in New York, NY.

IndexRUT
Employees49
IPOSep 09, 1997
Beta1.12
ATR, 14d0.18
Rel volume0.83
Short float8.67%
Insider own42.76%
Inst own45.61%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap225.63M
Enterprise Value109.52M
Income0.69M
Sales52.36M
Book/sh2.27
Cash/sh1.62
Dividend Est.-
Dividend TTM-
Dividend Ex-DateApr 07, 2026
Dividend Gr. 3/5Y- -
Payout0.00%
Employees49
IPOSep 09, 1997

Ratios

P/E345.05
Forward P/E-
PEG-
P/S4.31
P/B1.38
P/C1.94
P/FCF-
EV/EBITDA-
EV/Sales2.09
Quick Ratio18.40
Current Ratio24.57
Debt/Eq0.00
LT Debt/Eq0.00
Option/ShortYes / Yes

Earnings

EPS (ttm)0.01
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y-10.75% -14.51%
Sales past 3/5Y-5.13% -5.42%
EPS Y/Y TTM-99.10%
Sales Y/Y TTM-69.60%
EPS Q/Q54.67%
Sales Q/Q-49.73%
EarningsNov 09 AMC
EPS/Sales Surpr.- -

Ownership

Insider Own42.76%
Insider Trans0.00%
Inst Own45.61%
Inst Trans0.07%
ROA0.34%
ROE0.37%
ROIC0.42%
Gross Margin54.03%
Oper. Margin-14.20%
Profit Margin1.31%
SMA200.10%
SMA50-1.55%
SMA200-22.95%
Trades-

Technical

Shs Outstand71.86M
Shs Float41.13M
Short Float8.67%
Short Ratio5.76
Short Interest3.57M
52W High6.29 -50.04%
52W Low2.83 10.95%
Volatility8.60% 5.09%
ATR (14)0.18
RSI (14)49.37
Beta1.12
Rel Volume0.83
Avg Volume619.53K
Volume512,857

Performance

Perf Week-0.32%
Perf Month1.95%
Perf Quarter9.03%
Perf Half Y-27.15%
Perf YTD-41.91%
Perf Year-43.57%
Perf 3Y-14.64%
Perf 5Y-34.85%
Perf 10Y93.90%
Recom-
Target Price11.57
Prev Close3.13
Price3.14
Change %0.32%

Peers

Mkt cap
TickerCompanyMkt cap
EBSEmergent Biosolutions Inc310.55M
KMDAKamada Ltd469.02M
BCRXBiocryst Pharmaceuticals Inc1.97B
TNXPTonix Pharmaceuticals Holding Corp75.20M
NNVCNanoViricides Inc35.23M
ENTAEnanta Pharmaceuticals Inc337.86M
GOVXGeovax Labs Inc1.10M
NVAXNovavax Inc1.65B
VIRVir Biotechnology Inc2.25B
SNGXSoligenix Inc7.51M

Insider trading

6 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Miller Larry R.General CounselMar 25 '26Option Exercise0.006,920055,438Mar 26 06:07 PM
Luckshire Daniel JExecutive VP & CFOMar 13 '26Option Exercise0.0011,5030286,567Mar 17 04:11 PM
Hruby Dennis EEVP & Chief Scientific OfficerMar 13 '26Option Exercise0.0011,4450202,492Mar 17 04:09 PM
Miller Larry R.General CounselMar 13 '26Option Exercise0.0021,261059,705Mar 17 04:07 PM
Nguyen DiemChief Executive OfficerMar 13 '26Option Exercise0.0085,0450185,796Mar 17 04:05 PM
Nguyen DiemChief Executive OfficerJan 27 '26Option Exercise0.0055,9020123,555Jan 28 04:05 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
AVUVAvantis U.S. Small Cap Value ETFAUM: 32.39B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
DFSVUS Small Cap Value Portfolio ETF Class SharesAUM: 8.52B
DFATU.S. Targeted Value Portfolio-ETF Class SharesAUM: 14.47B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
DFMCU.S. Micro Cap Portfolio ETF Class SharesAUM: 212.10M
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B

News

latest 14 of 200
  • SIGA's Narrower Q3 Loss Masks A Revenue Air Pocket As US Contract Remains Unresolved And PEP Filing Slips To 2028 (Earnings Whispers) +5.16%
  • SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2026 (GlobeNewswire)
  • SIGA Announces Retirement of Chief Scientific Officer Dennis Hruby, Ph.D. (GlobeNewswire)
  • SIGA to Host Business Update Call on November 9, 2026, Following Release of Third-Quarter 2026 Financial Results (GlobeNewswire)
  • SIGA Secures Contract Valued at Up to $15 Million from Canadian Department of National Defence to Purchase TPOXX (GlobeNewswire)
  • SIGA Technologies Inc (SIGA) (Q2 2026) Earnings Call Highlights: Strong Revenue and Strategic ... (GuruFocus.com)
  • SIGA Reports Financial Results for Three and Six Months Ended June 30, 2026 (GlobeNewswire)
  • SIGA to Host Business Update Call on August 6, 2026, Following Release of Second-Quarter 2026 Financial Results (GlobeNewswire)
  • SIGA Reports Financial Results for Three Months Ended March 31, 2026 and Provides Business Update (GlobeNewswire)
  • SIGA to Host Business Update Call on May 7, 2026, Following Release of First-Quarter 2026 Financial Results (GlobeNewswire)
  • SIGA Declares Special Cash Dividend of $0.60 Per Share (GlobeNewswire) +6.85%
  • Mpox Is on the Rise in the U.S. 3 Vaccine Stocks Worth a Second Look. (Barrons.com) -8.06%
  • SIGA Technologies Inc (SIGA) Q4 2025 Earnings Call Highlights: Strong Financial Performance and ... (GuruFocus.com)
  • SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2025 and Provides Business Update (GlobeNewswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-09-0.040--1.32--
2026Q22026-08-060.170-0.17341.00--
2026Q12026-05-07-0.050--0.0486.24--
2025Q42026-03-10-0.080--0.0763.80--
2025Q32025-11-06-0.090--0.0892.62--
2025Q22025-08-050.490-0.49581.12--
2025Q12025-05-08-0.010--0.0067.04--
2024Q42025-03-110.630-0.64181.40--
2024Q32024-11-070.020-0.01910.01--
2024Q22024-08-010.030-0.02621.81--
2024Q12024-05-070.140-0.14425.43--
2023Q42024-03-121.010-1.016116.5--
2023Q32023-11-07-0.010--0.0069.24--
2023Q22023-08-08-0.040--0.0405.88--
2023Q12023-05-04-0.010--0.0138.32--
2022Q42023-03-02-0.010--0.01111.40--

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2010FY-0.620-0.350-0.62019.2021.68
2011FY0.0900.5400.09012.7031.05
2012FY-0.280-0.250-0.2809.0021.83
2013FY-0.330--0.3305.50-
2014FY---4.9703.14-
2020FY0.820-0.709124.96-
2021FY0.9100.8800.909133.67133.31
2022FY0.4600.6600.456110.78115.38
2023FY0.9501.0800.950139.9172.6
2024FY0.8201.0500.824138.72160.21
2025FY0.320-0.33094.5797.50
2026FY-1.700--237.44

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026FYS2026-10-2410059.8659.8659.86
2026FYS2026-08-1010159.8659.8659.86
2026FYS2026-05-2610066.3166.3166.31
2026FYS2026-03-1210166.3166.3166.31
2026FYS2026-03-10100226.55226.55226.55
2026FYS2025-11-11100226.55226.55226.55
2026FYS2025-11-10100226.55226.55226.55
2026FYS2025-11-09100226.55226.55226.55
2026FYS2025-11-08100226.55226.55226.55
2026FYS2025-11-07100226.55226.55226.55
2026FYS2025-11-06100226.55226.55226.55
2026FYS2025-11-05100226.55226.55226.55
2026FYS2025-11-04100226.55226.55226.55
2026FYS2025-11-03100226.55226.55226.55

Estimate history

EPS, annual-0.465.184-0.150.7090.9090.4560.950.8240.3240.0091
Period201720182019202020212022202320242025TTM
EPS, quarterly0.0190.641-0.0060.495-0.089-0.076-0.0480.173-0.04
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual12.269477.05426.742124.959133.67110.776139.917138.71994.57552.36
Period201720182019202020212022202320242025TTM
Sales, quarterly10.0181.4697.04181.122.623.7946.24341.0021.317
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual79.03980.76381.2777.19673.54472.67571.09271.40571.61171.855
Period201720182019202020212022202320242025MRQ
Shares, quarterly71.36971.40571.44171.5471.61171.61171.72471.84471.855
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue52.3694.57138.72139.92110.78133.67124.9626.74477.05
Cost of Goods Sold Incl. D&A24.0729.7031.2917.8310.4316.6014.801.7895.27
Gross Profit28.2964.87107.43122.09100.34117.07110.1624.96381.78
Selling, General and Administrative Excl. Other35.7241.1737.4538.4757.6427.9824.9426.5125.86
Research and Development16.0219.9612.3116.4322.539.9410.9413.3013.02
Other Operating Expense0.000.000.000.000.000.000.720.730.79
Operating Income-7.4423.7069.9883.6242.7089.0984.50-2.28355.14
Interest Expense0.000.000.000.000.000.003.0215.7715.48
Unusual Expense0.000.000.000.00-0.40-0.128.51-5.056.96
Net Income Before Taxes-2.6430.3876.0787.7844.1389.3173.51-10.18411.64
Income Taxes-3.327.1016.8619.7110.2319.8617.17-2.94-10.17
Consolidated Net Income0.6923.2859.2168.0733.9069.4556.34-7.24421.81
Net Income From Continuing Operations0.6923.2859.2168.0733.9069.4556.34-7.24421.81
Net Income0.6923.2859.2168.0733.9069.4556.34-7.24421.81
EPS (Recurring)0.010.320.820.950.450.910.78-0.195.24
EPS (Basic, Before Extraordinaries)0.010.330.830.950.460.920.71-0.095.28
EPS (Diluted)0.010.320.820.950.460.910.71-0.155.18
EBITDA-6.8324.2670.5284.1643.2289.6285.03-1.75355.20
Non-Operating Income (Expense)4.806.686.094.161.030.100.532.8278.94
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense2.842.912.881.621.410.920.991.541.80
Price To Earnings Ratio345.05345.054.00-3.525.326.57-1.00
Price To Sales Ratio4.674.643.122.874.894.304.6214.661.37
Gross Margin54.0368.5977.4487.2690.5887.5888.1693.3380.03
Operating Margin-14.2025.0650.4559.7638.5566.6567.62-8.5174.44
Net Margin1.3124.6142.6948.6530.6151.9645.09-27.0888.42
Shares Outstanding71.8671.6171.4071.0972.6873.5477.2081.2780.76
Market Capitalization225.61225.61343.76297.06370.50361.04364.50250.51411.08

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue1.3241.006.243.792.6281.127.0481.47
Cost of Goods Sold Incl. D&A0.5817.562.942.991.0025.550.1614.13
Gross Profit0.7423.443.300.801.6255.576.8867.34
Selling, General and Administrative Excl. Other7.269.548.6210.3011.849.899.1410.25
Research and Development2.644.393.955.047.054.403.463.34
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-6.5213.91-5.32-9.50-10.2245.68-2.2657.09
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-5.4814.85-4.04-7.96-8.3647.27-0.5758.58
Income Taxes-2.592.39-0.59-2.53-1.9911.79-0.1612.82
Consolidated Net Income-2.8912.46-3.45-5.43-6.3735.48-0.4145.76
Net Income From Continuing Operations-2.8912.46-3.45-5.43-6.3735.48-0.4145.76
Net Income-2.8912.46-3.45-5.43-6.3735.48-0.4145.76
EPS (Recurring)-0.040.17-0.05-0.08-0.090.49-0.010.64
EPS (Basic, Before Extraordinaries)-0.040.17-0.05-0.08-0.090.50-0.010.64
EPS (Diluted)-0.040.17-0.05-0.08-0.090.49-0.010.64
EBITDA-6.3714.06-5.17-9.35-10.0845.82-2.1257.22
Non-Operating Income (Expense)1.040.951.281.541.871.591.681.50
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.680.960.590.610.610.980.710.60
Price To Earnings Ratio345.0512.9314.605.197.058.495.304.00
Price To Sales Ratio4.674.884.094.633.802.603.253.09
Gross Margin56.2957.1752.8921.2061.7568.5097.7682.65
Operating Margin-495.0833.91-85.24-250.38-390.1756.31-32.0370.07
Net Margin-219.6830.40-55.33-143.12-242.9743.74-5.8056.17
Shares Outstanding71.8671.8471.7271.6171.6171.5471.4471.40
Market Capitalization225.61261.08339.07387.06579.60412.05313.58343.76

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments154.97155.40150.1598.79103.14117.89160.99112.1030.56
Short Term Receivables3.2621.1721.1345.4183.653.344.171.961.80
Inventories49.0549.5664.2239.2719.5120.279.652.912.98
Other Current Assets5.574.913.502.322.452.115.234.322.02
Total Current Assets212.86231.04238.99185.79208.75143.61180.04121.2937.36
Net Property, Plant & Equipment1.091.301.331.852.372.102.620.170.14
Total Investments and Advances0.000.000.000.000.000.000.0068.296.54
Intangible Assets0.900.900.900.900.900.900.900.900.90
Deferred Tax Assets4.9411.3611.536.793.073.1214.8912.2125.24
Other Assets0.190.242.080.250.290.680.861.0697.29
Total Assets219.98244.84254.84195.57215.37150.41199.30203.92167.48
Short Term Debt Incl. Current Port. of LT Debt0.600.550.560.530.470.4580.460.000.00
Accounts Payable0.821.341.463.362.031.283.051.691.33
Income Tax Payable0.418.0221.691.3119.210.92---
Other Current Liabilities16.1615.4230.4116.328.797.848.229.655.48
Total Current Liabilities17.9925.3354.1221.5230.4910.4891.7411.346.81
Long Term Debt0.200.800.901.502.101.902.4075.5571.05
Provision for Risks Charges0.000.000.000.000.000.000.000.00-
Deferred Tax Liabilities0.510.500.480.540.650.580.740.4822.81
Other Liabilities2.452.402.481.867.827.656.6513.64389.95
Total Liabilities21.1529.0357.9825.4141.0620.62101.52101.01490.62
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity198.82215.80196.86170.16174.31129.7997.78102.91-323.14
Total Shareholders Equity198.82215.80196.86170.16174.31129.7997.78102.91-323.14
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity198.82215.80196.86170.16174.31129.7997.78102.91-323.14
Total Liabilities & Stockholders Equity219.98244.84254.84195.57215.37150.41199.30203.92167.48
Book Value Per Share2.783.022.772.342.371.681.201.27-4.09
Tangible Book Value Per Share2.763.012.762.332.361.671.191.26-4.10
Full-Time Employees494645393942414137
Price to Book Ratio1.382.032.392.142.062.802.574.02-0.79
Return on Assets10.0223.7030.2316.5037.9732.22-3.59227.14-20.40
Return on Equity11.2328.7037.0919.6845.6849.51-7.22--
Return on Invested Capital11.7027.3434.4219.7539.3742.78-7.23236.36-
Quick Ratio9.107.163.236.816.2111.771.8610.445.05
Current Ratio11.839.124.428.636.8513.701.9610.705.49

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income0.6923.2859.2168.0733.9069.4556.34-7.24421.81
Depreciation0.600.560.540.540.520.520.530.530.07
Other Funds (Non Cash)3.854.95-6.492.631.581.7710.751.52-346.60
Funds from Operations2.0035.2253.4666.4432.1771.8679.22-7.6165.98
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-13.538.26-4.6928.369.44-60.37-7.70-10.592.89
Income Taxes Payable-0.06-7.61-13.6720.38-17.9018.29---
Cash from Operating Activities-11.5343.4748.7694.8041.6111.4971.52-18.2068.87
Capital Expenditures-0.04-0.36-0.04-0.020.00-0.05-0.02-0.03-0.10
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00-
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00-
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.0078.34
Cash from Investing Activities-0.04-0.36-0.04-0.020.00-0.05-0.02-0.0378.24
Cash Dividends Paid-43.40-43.12-42.67-32.14-32.940.000.000.000.00
Change in Capital Stock0.000.000.00-11.07-13.01-26.02-28.500.000.26
Repurchase of Common Pref Stock0.000.000.00-11.07-13.01-26.02-28.500.000.00
Sale of Common Pref Stock0.000.000.000.000.000.000.000.000.26
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00-85.910.000.00
Change in Long Term Debt0.000.000.000.000.000.00-85.910.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00-85.910.000.00
Net Financing Active Other Cash Flow-0.60-0.43-0.80-0.21-0.01-0.17-0.18-1.18-4.07
Other Financing Activities Uses-0.60-0.43-0.80-0.21-0.01-0.17-0.18-1.18-4.07
Cash from Financing Activities-44.00-43.55-43.46-43.42-45.96-26.20-114.60-1.18-3.81
Net Change in Cash-55.58-0.435.2551.36-4.35-14.75-43.10-19.41143.30
Free Cash Flow-11.5743.1248.7294.7841.6111.4471.50-18.2368.77
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow--71.386.4162.4350.218.08-9.50
Deferred Taxes & Investment Tax Credit-6.430.19-4.80-3.830.1211.61-2.42-9.30

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments116.38117.58145.56154.97171.96182.46
Short Term Receivables2.027.174.503.262.496.49
Inventories41.5941.1156.4949.0548.0135.62
Other Current Assets5.554.514.975.575.294.64
Total Current Assets165.54170.38211.53212.86227.75229.20
Net Property, Plant & Equipment1.381.531.671.091.201.05
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets0.900.900.900.900.900.90
Deferred Tax Assets4.712.795.094.941.563.97
Other Assets0.130.140.200.190.200.21
Total Assets172.65175.74219.39219.98231.60235.33
Short Term Debt Incl. Current Port. of LT Debt0.270.440.540.600.580.57
Accounts Payable0.480.916.310.825.031.19
Income Tax Payable0.030.030.400.410.104.18
Other Current Liabilities5.956.4757.9116.1619.1316.78
Total Current Liabilities6.747.8565.1617.9924.8422.72
Long Term Debt0.000.000.100.200.300.50
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities---0.51--
Other Liabilities2.662.602.512.452.982.80
Total Liabilities9.3910.4567.7721.1528.1226.02
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity163.25165.29151.62198.82203.48209.31
Total Shareholders Equity163.25165.29151.62198.82203.48209.31
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity163.25165.29151.62198.82203.48209.31
Total Liabilities & Stockholders Equity172.65175.74219.39219.98231.60235.33
Book Value Per Share2.272.302.112.782.842.93
Tangible Book Value Per Share2.262.292.102.762.832.91
Full-Time Employees---49--
Price to Book Ratio1.381.721.701.902.771.91
Return on Assets0.34-1.368.6810.0234.8838.40
Return on Equity0.37-1.4911.0011.2339.9443.61
Return on Invested Capital-1.777.54-2.28-2.73-3.1216.91
Quick Ratio18.4016.482.389.107.248.52
Current Ratio24.5721.723.2511.839.1710.09

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-2.8912.46-3.45-5.43-6.3735.48
Depreciation0.150.150.150.150.140.14
Other Funds (Non Cash)0.860.590.751.660.771.62
Funds from Operations-3.7915.50-3.21-6.50-3.0444.40
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital2.61-0.32-5.45-10.37-6.7718.68
Income Taxes Payable0.01-0.38-0.000.31-4.084.17
Cash from Operating Activities-1.1815.17-8.66-16.86-9.8163.08
Capital Expenditures0.000.000.00-0.04-0.29-1E-06
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities0.000.000.00-0.04-0.29-1E-06
Cash Dividends Paid-0.01-43.15-0.16-0.09-0.16-42.87
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.000.000.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow-0.01-0.00-0.580.00-0.24-0.03
Other Financing Activities Uses-0.01-0.00-0.580.00-0.24-0.03
Cash from Financing Activities-0.02-43.15-0.74-0.09-0.40-42.89
Net Change in Cash-1.20-27.98-9.40-16.99-10.5120.19
Free Cash Flow-1.1815.17-8.66-16.90-10.1063.08
Price to Free Cash Flow----8.946.14

Revenue breakdown

Product Sales and Supportive Services2024: 133.33M 2025: 88.05M
Research and Development2024: 5.39M 2025: 6.53M
Asia Pacific2024: 13.86M
Canada2024: 737.68K
EMEA2024: 8.38M
Non-US2025: 5.82M
United States2024: 115.74M 2025: 88.75M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-308.67%3.6M41.1M625.43K
2026-10-158.66%3.6M41.1M714.67K
2026-09-308.75%3.6M41.1M718.65K
2026-09-159.07%3.7M41.1M729.68K
2026-08-318.64%3.6M41.1M674.17K
2026-08-149.35%3.8M41.1M643.30K
2026-07-318.99%3.7M41.1M634.11K
2026-07-159.59%3.9M41.0M530.57K
2026-06-308.45%3.5M41.0M598.79K
2026-06-158.32%3.4M41.0M636.08K
2026-05-298.69%3.6M41.1M716.45K
2026-05-158.16%3.3M40.6M722.24K
2026-04-308.22%3.3M40.6M705.16K
2026-04-157.98%3.2M40.6M700.73K
2026-03-318.58%3.5M40.6M613.84K
2026-03-137.75%3.1M40.6M435.77K
2026-02-278.32%3.4M40.6M368.20K
2026-02-138.21%3.3M40.6M354.27K
2026-01-307.83%3.2M40.6M381.00K
2026-01-158.29%3.4M40.6M381.13K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call1.000.154.302.150.0003.000.000.965-0.0110.000
call2.000.003.300.000.0000.000.000.838-0.0550.001
call3.000.000.800.383.87258.000.000.651-0.0420.002
call4.000.000.550.104.2272710.000.485-0.0470.002
call5.000.000.050.102.5275150.000.175-0.0180.001
call6.000.000.150.153.18391.000.000.150-0.0200.001
call7.000.001.750.053.17567.000.000.085-0.0140.001
put1.000.000.050.004.9810.000.00-0.035-0.0100.000
put2.000.001.750.008.0500.000.00-0.162-0.0540.001
put3.000.000.700.054.11051.000.00-0.349-0.0410.002
put4.000.301.401.203.15829.000.00-0.515-0.0460.002
put5.000.402.651.156.5132270.00-0.888-0.0110.001
put6.000.805.000.0015.2910.000.00-0.906-0.0120.001
put7.001.806.000.0015.8080.000.00-0.915-0.0130.001

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-098-KCurrent report2026-11-09SEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-06-25S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-06-104Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-06-104Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-06-104Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-06-104Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-06-104Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-06-104Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-06-104Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-06-108-KCurrent report2026-06-09SEC
2026-05-08DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-05-0710-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-078-KCurrent report2026-05-07SEC
2026-04-28ARSAnnual report to security holders. 2025-12-31SEC
2026-04-28DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-28DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-09SEC
2026-03-264Statement of changes in beneficial ownership of securities2026-03-25SEC
2026-03-268-KCurrent report2026-03-26SEC
2026-03-174Statement of changes in beneficial ownership of securities2026-03-13SEC
2026-03-174Statement of changes in beneficial ownership of securities2026-03-13SEC
2026-03-174Statement of changes in beneficial ownership of securities2026-03-13SEC
2026-03-174Statement of changes in beneficial ownership of securities2026-03-13SEC
2026-03-1010-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-03-108-KCurrent report2026-03-10SEC
2026-01-284Statement of changes in beneficial ownership of securities2026-01-27SEC
2025-11-0610-QQuarterly report pursuant to Section 13 or 15(d)2025-09-30SEC
2025-11-068-KCurrent report2025-11-06SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.5.84%
AltraVue Capital, LLC3.24%
DIMENSIONAL FUND ADVISORS LP2.80%
VANGUARD CAPITAL MANAGEMENT LLC2.39%
AMERICAN CENTURY COMPANIES INC2.10%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP2.06%
FIRST WILSHIRE SECURITIES MANAGEMENT INC1.87%
AQR CAPITAL MANAGEMENT LLC1.74%
STATE STREET CORP1.58%
GEODE CAPITAL MANAGEMENT, LLC1.56%

Funds

Fund% owned
Avantis U.S. Small Cap Value ETF1.97%
VANGUARD TOTAL STOCK MARKET INDEX FUND1.68%
iShares Russell 2000 ETF1.58%
VANGUARD EXTENDED MARKET INDEX FUND0.65%
Fidelity Small Cap Index Fund0.65%
U.S. Targeted Value Portfolio0.64%
iShares Russell 2000 Value ETF0.55%
Royce Small-Cap Fund0.46%
U.S. SMALL CAP PORTFOLIO0.44%
Dimensional U.S. Targeted Value ETF0.42%

OakChart. SIGA. Cached 15 minutes.

Some panels did not load: ratings.